Last reviewed · How we verify
NCT05890404
SGM Evidenced-Based Mental Healthcare Implementation
NA trial testing LGBTQ-Affirmative CBT Training: Materials Only in CBT in 1,410 participants. Currently enrolling.
1 October 2027
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 1,410 |
| Start date | 8 February 2024 |
| Primary completion | 1 October 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- LGBTQ-Affirmative CBT Training: Materials Only
- LGBTQ-Affirmative CBT Training: Direct Training
- LGBTQ-Affirmative CBT Training: Local Supervision
Conditions studied
Sponsor
Yale University
Who can join
15 and older, any sex, with CBT or LGBTQ. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Implementing LGBTQ-affirmative CBT: study protocol for an effectiveness-implementation trial at 90 LGBTQ community centers.
Pachankis JE, Chiaramonte D, Baldwin HT, Prachniak C, et al · · 2025 · PMID 40691571 · DOI 10.1186/s12913-025-13136-3
Verify or expand the search:
- PubMed search for NCT05890404
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CBT
Currently open trials in the same condition.
- NCT06872840 — Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility · NA · recruiting
- NCT07042672 — Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity · recruiting
- NCT06983301 — Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice · NA · recruiting
- NCT05758987 — Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy · NA · recruiting
- NCT05549102 — CBT and the Neural Circuits of Anxiety · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05890404 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05890404.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing